Patents by Inventor Jennifer JENKINS-EVELETH

Jennifer JENKINS-EVELETH has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230130851
    Abstract: Described herein are modified fibroblast growth factor (FGF) polypeptides, pharmaceutical compositions and medicaments that include such modified FGF polypeptides, and methods of using such modified FGF polypeptides to treat or prevent conditions that benefit from administration of FGFs.
    Type: Application
    Filed: September 7, 2022
    Publication date: April 27, 2023
    Inventors: David EVELETH, Jennifer JENKINS-EVELETH, Amuthakannan SUBRAMANIAM, Ralph BRADSHAW
  • Patent number: 11479591
    Abstract: Described herein are modified fibroblast growth factor (FGF) polypeptides, pharmaceutical compositions and medicaments that include such modified FGF polypeptides, and methods of using such modified FGF polypeptides to treat or prevent conditions that benefit from administration of FGFs.
    Type: Grant
    Filed: May 4, 2018
    Date of Patent: October 25, 2022
    Assignee: TREFOIL THERAPEUTICS, INC.
    Inventors: David Eveleth, Jennifer Jenkins-Eveleth, Amuthakannan Subramaniam, Ralph Bradshaw
  • Publication number: 20200190158
    Abstract: Described herein are modified fibroblast growth factor (FGF) polypeptides, pharmaceutical compositions and medicaments that include such modified FGF polypeptides, and methods of using such modified FGF polypeptides to treat or prevent conditions that benefit from administration of FGFs.
    Type: Application
    Filed: May 4, 2018
    Publication date: June 18, 2020
    Inventors: David EVELETH, Jennifer JENKINS-EVELETH, Amuthakannan SUBRAMANIAM, Ralph BRADSHAW